A collaborative webinar with Diabetes Canada
Washington, DC, USA
September 18, 2019
2:00 pm – 3:00 pm
Over 90% of North Americans exceed the recommended intake limit for added sugars. This webinar, hosted jointly by ILSI North America and Diabetes Canada, focuses on the role of low-calorie sweeteners (LCS) as a tool for reducing intake of added sugars. Diabetes Canada has developed a position statement that emphasizes the urgent need for strategies to reduce the intake of added sugars by Canadians, especially those with or at risk of developing type 2 diabetes, and recognizes that LCS are one viable tool available for added sugars intake reduction.
This webinar will also review what is meant by an Acceptable Daily Intake (ADI) for food additives which include LCS, and why it confers protection. Results of a scoping review of the nutrition literature and the application of the ADI for LCS in that body of work will be presented. Speakers will address how the ADI can be used in nutrition research related to LCS, how to move toward a systematic approach for evaluating LCS intakes in nutrition studies, and the translation of this information for practice. Participants will have the opportunity to ask questions of the panelists.
Njwen Anyangwe, PhD
Toxicologist, US Food and Drug Administration
Joanne Lewis, RD, CDE
Director of Knowledge Innovation, Diabetes Canada
Daniele Wikoff, PhD
Health Sciences Practice Leader, ToxStrategies
Deepa Handu, PhD, RDN
Senior Scientific Director, The Academy of Nutrition and Dietetics
Marie Latulippe, MS, RDN
Senior Program Manager, ILSI North America
View the protocol for the scoping review on the Center for Open Science’s Open Science Framework.
Learn more about the ILSI North America Low-Calorie Sweeteners Committee.
Learn more about Diabetes Canada.